Clinical Trials Logo

Endometrium Cancer clinical trials

View clinical trials related to Endometrium Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03951415 Active, not recruiting - Clinical trials for Endometrial Neoplasms

Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer

DOMEC
Start date: July 8, 2019
Phase: Phase 2
Study type: Interventional

The DOMEC trial is designed as a Dutch Gynecological Oncology Group (DGOG), prospective, multi-center, phase II study for 55 patients with advanced (recurrent, refractory or metastatic) endometrial cancer or carcinosarcoma of the uterus to investigate the efficacy of the combination therapy of olaparib tablets and durvalumab IV.

NCT ID: NCT01466777 Active, not recruiting - Endometrium Cancer Clinical Trials

Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy

Start date: November 2010
Phase: N/A
Study type: Interventional

The aim of this study is to compare the robotic-assisted laparoscopic surgery to the traditional laparoscopic surgery in endometrial cancer patients. The study is prospective and the patients are randomised into two groups of 50 patients each. Randomisation is done with Minim-programme and patients age and Body mass index are taken into account. The primary endpoint is the operation time. The number of patients in this study is based on the non-inferiority design. Presumption is that the operation time in robotic-assisted laparoscopy will be 25% longer. Secondary endpoints include: 1. bleeding 2. complications 3. conversions 4. number of pelvic lymph nodes